Extracorporeal life support as ultimate strategy for refractory severe cardiogenic shock induced by tako-tsubo cardiomyopathy: A new effective therapeutic option

Massimo Bonacchi, Serafina Valente, Guy Harmelin, Gian Franco Gensini, Guido Sani

Research output: Contribution to journalArticle

Abstract

We report a possible new therapeutic strategy, using extracorporeal cardiopulmonary support (ECLS), for severe refractory cardiogenic shock (SRCS) in a patient with Tako-tsubo cardiomyopathy (TC). TC is a syndrome characterized by left ventricular wall motion abnormalities, without coronary artery disease, mimicking the diagnosis of acute coronary syndrome. This ventricular dysfunction can be reversible; however, it can progress into refractory cardiogenic shock with limited therapeutic options available. For the first time in a Tako-tsubo patient with refractory cardiogenic shock, we used ECLS treatment in order to rest the heart, sustain circulation and end-organ perfusion, and promote potential ventricular recovery. ECLS might be the selected treatment for SRCS in patients with TC, and seems to be an effective and useful ultimate therapeutic strategy for preventing death.

Original languageEnglish
Pages (from-to)866-870
Number of pages5
JournalArtificial Organs
Volume33
Issue number10
DOIs
Publication statusPublished - 2009

Keywords

  • Extracorporeal life support
  • Myocardial recovery
  • Takotsubo cardiomyopathy

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Fingerprint Dive into the research topics of 'Extracorporeal life support as ultimate strategy for refractory severe cardiogenic shock induced by tako-tsubo cardiomyopathy: A new effective therapeutic option'. Together they form a unique fingerprint.

  • Cite this